Evidence / Timmers et al. · 2011
A short human crossover study of resveratrol
Selected research. Study type, product relevance and limitations are shown separately.
Editorial study summary
- Study type
- Randomized, double-blind, placebo-controlled crossover trial.
- Product relevance
- Ingredient evidence from a different resveratrol intervention.
- Sample or population
- 11 men with obesity who were otherwise healthy.
- Studied dose
- 150 mg/day of resveratrol or placebo.
- Duration
- 30 days.
- Finding
- The authors reported differences in resting and sleeping metabolic rate and several muscle and blood measures during resveratrol use.
- Limitations
- A small, short trial with metabolic measurements cannot establish durable clinical benefit.
- Study quality
- Controlled crossover with multiple physiological outcomes. Editorial review was limited to the abstract. No formal risk-of-bias rating was assigned.
- Funding and disclosures
- Funding and conflicts were not verified from the abstract.
The studies discussed here examine ingredients or other formulations. They do not establish results for this DR.MORGAN finished product.